Position in PFE
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$10,915,536
-$2,141,045 QoQ
Shares Held
453,303
-2.5% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#398
of 2,820 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $421,884,223 across 14 Drug Manufacturers - General names. PFE ranks #6 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
596,837 | $150,188,062 | |
| 2 | JNJ |
Johnson & Johnson
|
391,709 | $99,482,334 | |
| 3 | LLY |
ELI LILLY & Co
|
53,616 | $64,308,643 | |
| 4 | AMGN |
Amgen Inc
|
167,825 | $60,772,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
172,406 | $22,154,171 | |
| 6 | PFE |
Pfizer Inc
This page
|
453,303 | $10,915,536 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
113,175 | $6,521,142 | |
| 8 | AZN |
Astrazeneca PLC
|
20,928 | $3,968,367 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,915,536 | 453,303 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $13,056,581 | 464,978 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $11,452,281 | 459,931 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,117,191 | 475,557 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $12,089,966 | 498,761 | Shares | Sole | 2025-10-17 | |
| 2025-03-31 | $13,325,899 | 525,884 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $14,980,191 | 564,651 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $18,351,721 | 634,130 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $18,436,301 | 658,910 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $17,725,895 | 638,771 | Shares | Sole | 2024-06-20 | |
| 2023-12-31 | $20,729,231 | 720,015 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $27,087,948 | 816,640 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $32,697,872 | 891,436 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $67,770,962 | 1,661,053 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $96,441,366 | 1,882,150 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $80,674,448 | 1,843,566 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $95,391,037 | 1,819,398 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $90,075,140 | 1,739,910 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $98,969,925 | 1,676,036 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $70,368,445 | 1,636,095 | Shares | Sole | 2021-11-30 | |
| 2021-06-30 | $63,801,390 | 1,629,249 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $58,766,183 | 1,622,031 | Shares | Sole | 2021-06-15 | |
| 2020-12-31 | $60,357,136 | 1,639,694 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $59,888,982 | 1,631,854 | Shares | Sole | 2020-12-21 | |
| 2020-06-30 | $50,899,793 | 1,556,567 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $50,238,049 | 1,539,158 | Shares | Sole | 2020-07-01 | |
| No filing history on record for this holder in this stock. | ||||||